You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mantle cell lymphomas (MCL)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Mantle Cell Lymphoma Trial in Beijing (DTRMWXHS-12)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Beijing, China
    Peking University Cancer Hospital
Aug 18, 2021

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Eprenetapopt, Venetoclax)

Withdrawn
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Feb 23, 2022

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

Not yet recruiting
  • Aggressive B-Cell Non-Hodgkin's Lymphoma
  • +4 more
  • (no location specified)
Dec 16, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Mantle Cell Lymphoma (MCL) Trial in Japan (Ibrutinib, Venetoclax)

Active, not recruiting
  • Mantle Cell Lymphoma (MCL)
  • Nagoya-shi, Aichi, Japan
  • +11 more
Apr 4, 2022

CD19+ Diffuse Large B-cell Lymphomas, Follicular Lymphomas, Mantle Cell Lymphomas Trial in Philadelphia (Pembrolizumab)

Completed
Has Results
  • CD19+ Diffuse Large B-cell Lymphomas
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 20, 2021

Refractory Mantle Cell Lymphoma, Relapsed Mantle Cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Refractory Mantle Cell Lymphoma
  • Relapsed Mantle Cell Lymphoma
  • Beijing, Beijing, China
  • +13 more
Oct 8, 2021

Ibrutinib Combined With Bendamustine and Rituximab in Newly

Recruiting
  • Mantle Cell Lymphoma (MCL)
    • Beijing, Beijing, China
      Peking University Third Hospital
    May 31, 2022

    Mantle Cell Lymphoma (MCL) Trial in China (LP-168)

    Not yet recruiting
    • Mantle Cell Lymphoma (MCL)
    • Hefei, Anhui, China
    • +29 more
    Feb 7, 2023

    Mantle Cell Lymphoma Trial in China (ICP-022)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Hefei, Anhui, China
    • +30 more
    Jul 5, 2022

    B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

    Active, not recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Anti-OX40 Antibody BMS 986178
    • +3 more
    • Palo Alto, California
      Stanford University, School of Medicine
    May 3, 2022

    CCND1 Positive, CCND2 Positive, CCND3 Positive Trial in Houston (drug, other, biological)

    Active, not recruiting
    • CCND1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 11, 2022

    Diffuse Large B-cell Lymphoma(DLBCL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma (FL) Trial in Worldwide (AMG 562)

    Completed
    • Diffuse Large B-cell Lymphoma(DLBCL)
    • +2 more
    • AMG 562
    • Duarte, California
    • +11 more
    Feb 22, 2022

    Lymphoma, Mantle-Cell Trial in Italy (Venetoclax)

    Active, not recruiting
    • Lymphoma, Mantle-Cell
    • Alessandria, Italy
    • +34 more
    Aug 1, 2022

    MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

    Active, not recruiting
    • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
    • +9 more
    • BTK inhibitor PCI-32765
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    Jun 27, 2022

    MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)

    Recruiting
    • MCL
    • Mantle Cell Lymphoma
    • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
    • Odense, Denmark
    • +21 more
    Feb 11, 2022

    Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

    Not yet recruiting
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    May 16, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +7 more
    • Manchester, United Kingdom
    • +2 more
    Aug 11, 2022

    Chronic Lymphocytic Leukemia, Chronic Graft-versus-host-disease, Mantle Cell Lymphoma Trial in Poland (Acalabrutinib 2x100 MG

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Acalabrutinib 2x100 MG Oral Capsule + alloSCT
    • Warszawa, Mazowieckie, Poland
    • +5 more
    Dec 23, 2021

    A Disease Registry of Patients With Mantle Cell Lymphoma

    Active, not recruiting
    • Mantle Cell Lymphoma
      • Montgomery, Alabama
      • +33 more
      Oct 28, 2022

      Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

      Recruiting
      • Non Hodgkin Lymphoma (NHL)
      • +6 more
      • 8/12-Day Production of Car-T Cells
      • +2 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin and Froedtert Hospital
      Jul 1, 2022

      Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

      Recruiting
      • Non-Hodgkin's Lymphoma (NHL)
      • +4 more
      • Indianapolis, Indiana
      • +1 more
      Jul 12, 2022